Diabetes Risk Scores: From development to population-wide implementation

Diabetes Risk Scores: From development to population-wide implementation | Recording

Overview

The International Diabetes Federation (IDF) has estimated that the number of adults with diabetes is expected to rise from 425 million in 2017 to 629 million by 2045. Type 2 diabetes mellitus does not cause specific symptoms for many years at onset, which explains why between 25%-50% of the cases of Type 2 diabetes mellitus remain undiagnosed at any time in the community. Plasma glucose either fasting or 2 hours after a 75g glucose load and HbA1c levels are recommended methods for Type 2 diabetes mellitus diagnosis in the general population. However, these are invasive, expensive, and time-consuming procedures and, hence, are not suitable for mass screening. It has been shown that the most cost-efficient method for Type 2 diabetes mellitus screening in the general population is the use of a non-invasive tool for risk stratification as the first step followed by a blood test for glycaemia. Thus, screening for impaired glucose regulation (IGR) should be targeted to individuals at high risk of Type 2 diabetes mellitus. This webinar provides a brief overview of the current experience in developing and implementing diabetes risk scores in different parts of the world.

Speakers and Moderators

Speakers:
Jaakko Tuomilehto, MD, PhD
Professor Emeritus of Public Health of University of Helsinki, Finland

Pablo Aschner, MD
Associate Professor of Endocrinology, Javeriana University School of Medicine

Nanditha Arun, MD
Director and Consultant Diabetologist of Dr. A. Ramachandran's Diabetes Hospitals

Moderators:
Elisabetta Patorno, MD, DrPH

Noël Barengo, MD, PhD, MPH

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account